Search clinical trials for: Daratumumab IV
Total 3507 results
-
Janssen Research & Development, LLCActive, not recruitingSmoldering Multiple MyelomaUnited States, Netherlands, Belgium, Canada, Israel, Czechia, Denmark, Japan, Hungary, Turkey, United Kingdom, Spain, Sweden, France, Germany, Italy, Russian Federation, Poland, Mexico, Australia, Brazil, Greece, Argentina, Norway
-
Boston Medical CenterJanssen PharmaceuticalsCompleted
-
Ostfold Hospital TrustOdense University Hospital; Oslo University Hospital; Haukeland University Hospital and other collaboratorsActive, not recruiting
-
Ronald WittelesCompletedHeart Transplant Failure and Rejection | AllosensitizationUnited States
-
University of ArkansasJanssen Scientific Affairs, LLCRecruiting
-
Incyte CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany
-
National Cancer Institute (NCI)RecruitingLymphoma, Primary EffusionUnited States
-
Charite University, Berlin, GermanyJanssen-Cilag G.m.b.H; Labor Berlin-Charité Vivantes G.m.b.H; Deutsches Rheuma-Forschungszentrum... and other collaboratorsNot yet recruiting
-
Marc L Gordon, MDJanssen Scientific Affairs, LLCCompletedAlzheimer DiseaseUnited States
-
Hoffmann-La RocheCompletedMultiple MyelomaUnited States, Australia, United Kingdom
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, France, United Kingdom, Belgium, Germany, Israel, Australia, Sweden, Canada, Netherlands, Austria, Ireland, Denmark
-
Memorial Sloan Kettering Cancer CenterTrillium Therapeutics Inc.Active, not recruitingMultiple MyelomaUnited States
-
Assistance Publique - Hôpitaux de ParisJanssen, LPCompletedKidney Transplant Rejection | Antibody-mediated Rejection | AllosensitizationFrance
-
Thomas Jefferson UniversityJanssen Scientific Affairs, LLCActive, not recruitingPlasma Cell MyelomaUnited States
-
Hoag Memorial Hospital PresbyterianRecruiting
-
Polish Myeloma ConsortiumJanssen-Cilag Ltd.; Bioscience, S.A.Recruiting
-
TakedaTerminatedRelapsed and/or Refractory Multiple Myeloma (RRMM)United States, Canada
-
Georgetown UniversityJanssen, LPRecruitingMonoclonal Gammopathy of Undetermined Significance | Peripheral NeuropathyUnited States
-
Institute of Hematology & Blood Diseases HospitalNot yet recruiting
-
Dartmouth-Hitchcock Medical CenterActive, not recruitingHemolytic AnemiaUnited States
-
Corvus Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterWithdrawn
-
Janssen Research & Development, LLCActive, not recruitingA Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple MyelomaMultiple MyelomaUnited States, Australia, France, United Kingdom, Germany, Israel, Turkey, Netherlands, Canada, Russian Federation, Czechia
-
Institute of Hematology & Blood Diseases HospitalRecruiting
-
Barry A. BoilsonJanssen Biotech, Inc.Enrolling by invitation
-
Carl Ola Landgren, MD, PhDJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaAustralia, Poland, United Kingdom, United States, Belgium, Germany, Spain, Argentina, Portugal, Bulgaria, Romania, Serbia, Turkey, Ukraine, Japan, Greece, Korea, Republic of, Brazil, Russian Federation, Hungary, Czechia, Croatia, Ge... and more
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple MyelomaUnited States
-
Barbara Ann Karmanos Cancer InstituteBristol-Myers Squibb; Janssen Pharmaceuticals; Multiple Myeloma Research ConsortiumRecruitingMultiple MyelomaUnited States
-
CelgeneCompletedMultiple MyelomaUnited States, Spain, Austria, Greece, Netherlands, Sweden
-
BiocadRecruitingMultiple MyelomaRussian Federation
-
French Innovative Leukemia OrganisationJanssen, LPActive, not recruitingRelapsed or Refractory Chronic Lymphocytic LeukemiaFrance
-
Gruppo Italiano Malattie EMatologiche dell'AdultoNot yet recruitingT-Lymphocytic Leukemia, Acute
-
Janssen Research & Development, LLCApproved for marketingMultiple MyelomaUnited States, United Kingdom, Spain, Brazil, Russian Federation, Japan
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Spain, Netherlands, Sweden, Denmark, France
-
M.D. Anderson Cancer CenterJanssen-Cilag div. of Johnson&Johnson SEWithdrawnProstate Cancer | Malignant Neoplasms of Male Genital Organs
-
M.D. Anderson Cancer CenterJanssen Scientific Affairs, LLCWithdrawnMalignant Neoplasms Stated as Primary Lymphoid Haematopoietic
-
Institute of Hematology & Blood Diseases Hospital...Sinocelltech Ltd.RecruitingHemophilia A With InhibitorChina
-
Seoul National University HospitalUnknownPlasmacytoma | Multiple Myeloma in Relapse | DaratumumabKorea, Republic of
-
Institute of Hematology & Blood Diseases HospitalRecruitingAplastic Anemia | Platelet Transfusion RefractorinessChina
-
Mayo ClinicRecruitingProliferative Glomerulonephritis With Monoclonal IgG DepositsUnited States
-
The First Affiliated Hospital of Soochow UniversityNot yet recruitingNewly Diagnosed Multiple Myeloma
-
Dana-Farber Cancer InstituteJanssen Pharmaceuticals; The Leukemia and Lymphoma Society; Multiple Myeloma... and other collaboratorsActive, not recruitingSmoldering Multiple Myeloma | Monoclonal GammopathyUnited States
-
University Medical Center GroningenHuman Genome Sciences Inc.CompletedAdvanced Cervical CancerNetherlands
-
West Virginia UniversityRecruiting
-
Dana-Farber Cancer InstituteJanssen, LPCompletedWaldenström MacroglobulinemiaUnited States
-
Wake Forest University Health SciencesJanssen Research & Development, LLCWithdrawnMultiple MyelomaUnited States
-
Hellenic Society of HematologyJanssen PharmaceuticalsUnknown